CELC Celcuity Inc.

Celcuity Inc is a cellular analysis company. The company is discovering new cancer sub-types and commercializing diagnostic tests.

As of 07/01/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  09/20/2017
Outstanding shares:  14,936,190
Average volume:  117,067
Market cap:   $135,919,329
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDH6M05
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.20
PS ratio:   0.00
Return on equity:   -56.46%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy